New Delhi, Dec 17: India and the European Union will hold their long-pending summit in the first half of next year and resume negotiations on a free trade agreement, in efforts to bring back the relationship back on track.
Newly-appointed ambassador of European Union Tomasz Kozlowski said the issue of European Union restricting sale of around 700 generic drugs clinically tested by India’s GVK Biosciences does not stand anymore and both are now set to open a “new page” in their ties. FTA talks between the two sides will be held in January.
“The summit meeting will be held in first half of 2016. We are now working on mutually convenient dates for the summit,” he told reporters while describing India an engine of growth of the global economy.
The last India-EU Summit had taken place in 2012. The India-EU ties witnessed some strain after the 28-member bloc had not responded to New Delhi’s proposal for a brief visit by Prime Minister Narendra Modi to Brussels, the EU headquarters during his trip to France, Germany and Canada in April.
The summit is slated to be held in Brussels.
Kozlowski said both sides will resume talks on the proposed free trade agreement next month. The talks, launched in June 2007, remain stuck as both sides are not satisfied with each other’s offers.
After a gap of about two years, Chief negotiators of India and the European Union were expected to resume negotiations on August 28here but India had deferred the talks after EU imposed a ban on around 700 pharma products, which were clinically tested by GVK Biosciences.
The envoy said EU never banned Indian drugs and the issue was of testing and certification. Now, he, said both Indian exporters and European importers have managed certification for the drugs from other agencies and it was no more an issue.
